Additionally, MYC amplification was a recurrent finding in the breast angiosarcoma cases in our cohort; this finding is consistent with prior studies, which have found the consistent presence of high-level MYC amplification in radiation-associated angiosarcoma [23,24,25]. The gene discussed is MYC; the disease is breast angiosarcoma.